Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Glial Activation in Psychotic Disease States
NCT03257592Phase 1Terminated
- Sponsor
- Johns Hopkins University
- Start
- Aug 2010
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Sensitivity and Specificity of ([11C]DPA)-713 PET brain imaging. Started Aug 2010; status: terminated.
Beyond the preview
Go deeper on NCT03257592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257592.